A Pediatric Infectious Diseases Perspective of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Novel Coronavirus Disease 2019 (COVID-19) in Children
Andi L. Shane(Children's Healthcare of Atlanta), Karen L. Kotloff(University of Maryland, Baltimore), Felice C. Adler‐Shohet(Children's Hospital of Orange County), Abdulsalam O Alsulami(University of Alabama at Birmingham), Julianne E. Burns(Children's Hospital of Philadelphia), Lisa Saiman(NewYork–Presbyterian Hospital), Taito Kitano(University of Toronto), Alice I. Sato(Children's Hospital & Medical Center), Jonathan D. Crews(Baylor College of Medicine), Sharon Nachman(State University of New York), Kengo Inagaki(University of Michigan), Carol Kao(Emory University), Surabhi B Vora(University of Washington), Coleen K. Cunningham(Duke Medical Center), Beatriz Larrú Martínez(University of Liverpool), Claudia Espinosa(University of Louisville), Jeffery J. Auletta(Nationwide Children's Hospital), Vanessa Raabe(Unknown), Roberto P. Santos(Jackson Memorial Hospital), Samuel R. Dominguez(Children's Hospital Colorado), Ibukunoluwa Akinboyo(Duke University), Frank Zhu(Medical College of Wisconsin), Charles R. Woods(University of Tennessee at Chattanooga), Mundeep K. Kainth(Northwell Health)
Cited by 44
Related Papers
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
|New England Journal of Medicine|2020|2.7k
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
|Nature|2020|1.6k
Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet Infectious Diseases|2017|1.4k